Speech And Gait In Newly Diagnosed Parkinson’s Disease: Support For Early Rehabilitation
Objective: To describe the prevalence of self-reported speech difficulties in newly diagnosed Parkinson’s disease (PD) and to explore its associations with dysphagia, hypersalivation (HS) and…Association of Serum Linoleic Acid-containing Plasmalogens With Parkinson’s Disease: the PPMI Study
Objective: To investigate the associations of serum ethanolamine plasmalogens (PlsEtns) with Parkinson’s disease (PD) diagnosis and motor progression. Background: Altered plasmalogen levels have been reported…Peripheral neuropathy (NP) in advanced Parkinson’s disease (PD) patients treated with continuous subcutaneous foslevodopa/foscarbidopa (fLD/fCD)
Objective: To assess peripheral NP occurrence and clinico-electrophysiological features in patients with advanced PD patients treated with continuous subcutaneous fLD/fCD. Background: Continuous subcutaneous fLD/fCD is effective…Reframing Treatment Paradigms: The Rise of Cell and Gene Therapies in Parkinson’s Disease
Objective: To characterize the global clinical landscape and temporal evolution of disease modifying cell and gene therapy trials in Parkinson's disease (PD), including modality distribution,…Effectiveness aNd use of fosleVOdopa-foscarbidopa in advanced Parkinson disease in real Life setting in France (ENVOL study): interim analysis
Objective: To assess the real-world (RW) effectiveness of continuous subcutaneous infusion of foslevodopa/foscarbidopa (LDp/CDp) over a 12-month follow-up. Background: LDp/CDp is a continuous 24-hour subcutaneous…Burden and Geographic Distribution of Parkinson’s Disease in Mexico: A GBD 2021 Analysis (1990-2023)
Objective: To characterize the burden and geographic distribution of PD in Mexico using Global Burden of Disease (GBD) 2021 data. Background: Parkinson's disease (PD) represents…Opicapone for Management of Sleep Disturbances in Parkinson’s Disease: Post-hoc Analysis of the OASIS trial in Patients With and Without Probable RBD
Objective: To evaluate opicapone’s effect on sleep disturbances, motor/non-motor symptoms and quality of life in Parkinson's disease (PD) patients with and without probable Rapid eye…Cognitive and neuropsychiatric effects of home-based, remotely supervised strength exercise combined with guideline-based aerobic physical activity modification in Parkinson’s Disease: a randomized controlled trial
Objective: To evaluate the effects of a 24-week home-based, remotely supervised strength exercise program combined with guideline-based aerobic physical activity modification on cognitive function and…Task-Dependent Modulation of Reflexive and Voluntary Saccades in Parkinson Disease and Multiple System Atrophy
Objective: The present study aimed to quantitatively compare reflexive and voluntary saccades in patients with Parkinson’s disease (PD) and multiple system atrophy (MSA), and to…Sensor-based assessment of axial symptoms in Parkinson’s disease
Objective: To investigate whether inertial sensor–derived metrics can objectively quantify axial symptoms in Parkinson’s disease (PD), focusing on posture and postural instability. Background: Axial symptoms…
- « Previous Page
- 1
- …
- 46
- 47
- 48
- 49
- 50
- …
- 553
- Next Page »